The Carolina Nanoformulation workshop is a unique training workshop about Nanotechnology-based approaches to address Pharma and Biopharma needs for delivery of clinically relevant molecules.
CCNE focuses on exploiting the host response through nano approaches for cancer disease management and treatment . CCNE proposes developing targeted methods for the delivery of biologics, immunologic-modifiers and chemotherapies against melanoma and non-small cell lung cancers, utilizing innovative nanotechnologies developed here at UNC-Chapel Hill.
The Nanomedicine and Drug Delivery Symposium is the key annual event for researchers developing next-generation delivery vehicles — targeted, responsive, biodegradable nanomaterials to make diagnostics more sensitive and drugs more effective.
Sakai site for program participants
The Center for Nanotechnology in Drug Delivery was established in June 2007 in the UNC Eshelman School of Pharmacy. CNDD’s efforts are aimed at improving health by enhancing the efficacy and safety of new drugs and imaging agents through the discovery and application of innovative methods of drug delivery.
TransNanoForm was established in 2013 as part of Center for Nanotechnology in Drug Delivery at UNC-Chapel Hill (CNDD), the word leader in nanomedicine and drug delivery research. The CNDD is a joint venture of UNC Eshelman School of Pharmacy and the UNC School of Medicine and is a component of the Carolina Institute for Nanomedicine (CINaM).
The Nanomedicines Characterization Core Facility implements the CNDD mission of accelerating translation of new nanomedicines into clinic by providing comprehensive physicochemical characterization of nanoscale entities.
NCore is an open resource and functions on a fee for service basis. We welcome users from academia as well as from industry, government labs and other institutions to utilize our experience and our technological infrastructure.
As part of the Center for Strategic Scientific Initiatives, the Alliance for Nanotechnology in Cancer works in concert with other NCI advanced technology initiatives to provide the scientific foundation and team science that is required to transform cancer research and care.
With research that spans the spectrum from the laboratory to the bedside to the community, UNC Lineberger faculty work to understand the causes of cancer at the genetic and environmental levels, to conduct groundbreaking laboratory research, and to translate findings into pioneering and innovative clinical trials.